Valeo Pharma Income Statement

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jul '24 Jul 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020	Oct '19 Oct 31, 2019
Revenue	53.38	53.91	27.75	13.56	7.47	6.58
Revenue Growth (YoY)	-0.17%	94.31%	104.65%	81.49%	13.58%	50.09%
Cost of Revenue	41.36	39.33	19.23	9.41	6.09	5.18
Gross Profit	12.02	14.58	8.52	4.14	1.38	1.4
Selling, General & Admin	27.85	28.98	24.72	14.53	5.16	4.81
Operating Expenses	28.23	29.85	25.67	15.53	5.63	5.14
Operating Income	-16.21	-15.27	-17.15	-11.38	-4.25	-3.74
Interest Expense	-15.41	-13.79	-6.46	-1.36	-0.6	-0.11
Interest & Investment Income	3.73	3.75	0.17	0	0	-
Currency Exchange Gain (Loss)	-1.92	-0.82	-1.26	0.11	-0	0
Other Non Operating Income (Expenses)	0.49	0.28	0.24	-0.17	0.18	0.23
EBT Excluding Unusual Items	-29.32	-25.85	-24.46	-12.8	-4.67	-3.62
Asset Writedown	-1.91	-1.51	-2.73	-0.44	-0.04	-
Other Unusual Items	-0.99	-0.46	0.27	-1	-0.05	-
Pretax Income	-32.12	-27.81	-26.92	-14.23	-4.76	-3.62
Income Tax Expense	-	-	-1.17	-	-	-
Net Income	-32.12	-27.81	-25.75	-14.23	-4.76	-3.62
Net Income to Common	-32.12	-27.81	-25.75	-14.23	-4.76	-3.62
Shares Outstanding (Basic)	88	86	81	70	58	50
Shares Outstanding (Diluted)	88	86	81	70	58	50
Shares Change (YoY)	5.42%	6.50%	15.63%	20.76%	16.78%	39.09%
EPS (Basic)	-0.37	-0.32	-0.32	-0.20	-0.08	-0.07
EPS (Diluted)	-0.37	-0.32	-0.32	-0.20	-0.08	-0.07
Free Cash Flow	-4.02	-16.17	-28.86	-13.22	-5.36	-2.33
Free Cash Flow Per Share	-0.05	-0.19	-0.36	-0.19	-0.09	-0.05
Gross Margin	22.51%	27.05%	30.70%	30.56%	18.49%	21.30%
Operating Margin	-30.37%	-28.32%	-61.80%	-83.96%	-56.85%	-56.82%
Profit Margin	-60.18%	-51.58%	-92.80%	-104.99%	-63.73%	-54.96%
Free Cash Flow Margin	-7.54%	-30.00%	-104.03%	-97.49%	-71.75%	-35.46%
EBITDA	-14.1	-13.03	-16.1	-10.98	-4.01	-3.64
EBITDA Margin	-26.41%	-24.17%	-58.03%	-80.95%	-53.64%	-55.36%
D&A For EBITDA	2.11	2.23	1.05	0.41	0.24	0.1
EBIT	-16.21	-15.27	-17.15	-11.38	-4.25	-3.74
EBIT Margin	-30.37%	-28.32%	-61.80%	-83.96%	-56.85%	-56.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.